28018128|t|Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs.
28018128|a|Purpose. Topotecan and belotecan are camptothecin derivatives that are used to treat small cell lung cancer (SCLC). This study compared the toxicities and efficacies of belotecan and topotecan monotherapies in patients with SCLC. Methods. We retrospectively reviewed data from 94 patients with SCLC (with or without prior chemotherapy) who were treated using belotecan monotherapy (n = 59, 188 cycles) or topotecan monotherapy (n = 35, 65 cycles) between September 2003 and December 2011. Results. Thrombocytopenia occurred during 42% and 61.5% of the belotecan and topotecan cycles, respectively (p = 0.007). Significant differences between belotecan and topotecan were also observed for grade 4/5 lung infection (3.2% versus 10.8%, resp.; p = 0.003), all-grade headache (3.2% versus 10.8%, resp.; p = 0.017), and grade 4/5 increased liver enzymes (0.5% versus 4.6%, resp.; p = 0.023). The median TTPDs, CSSs, and OSs were 14 months and 11.6 months (p = 0.646), 10 months and 7 months (p = 0.179), and 34.5 months and 21.4 months (p = 0.914) after belotecan and topotecan monotherapy, respectively. Conclusions. Belotecan monotherapy may be safer than topotecan monotherapy in SCLC patients. And in terms of efficacy, belotecan could be comparable to topotecan monotherapy.
28018128	7	17	Toxicities	Disease	MESH:D064420
28018128	21	30	Belotecan	Chemical	MESH:C116963
28018128	34	42	Patients	Species	9606
28018128	48	70	Small Cell Lung Cancer	Disease	MESH:D055752
28018128	111	123	Camptothecin	Chemical	MESH:D002166
28018128	142	151	Topotecan	Chemical	MESH:D019772
28018128	156	165	belotecan	Chemical	MESH:C116963
28018128	170	182	camptothecin	Chemical	MESH:D002166
28018128	218	240	small cell lung cancer	Disease	MESH:D055752
28018128	242	246	SCLC	Disease	MESH:D055752
28018128	273	283	toxicities	Disease	MESH:D064420
28018128	302	311	belotecan	Chemical	MESH:C116963
28018128	316	325	topotecan	Chemical	MESH:D019772
28018128	343	351	patients	Species	9606
28018128	357	361	SCLC	Disease	MESH:D055752
28018128	413	421	patients	Species	9606
28018128	427	431	SCLC	Disease	MESH:D055752
28018128	492	501	belotecan	Chemical	MESH:C116963
28018128	538	547	topotecan	Chemical	MESH:D019772
28018128	631	647	Thrombocytopenia	Disease	MESH:D013921
28018128	685	694	belotecan	Chemical	MESH:C116963
28018128	699	708	topotecan	Chemical	MESH:D019772
28018128	775	784	belotecan	Chemical	MESH:C116963
28018128	789	798	topotecan	Chemical	MESH:D019772
28018128	832	846	lung infection	Disease	MESH:D012141
28018128	896	904	headache	Disease	MESH:D006261
28018128	1182	1191	belotecan	Chemical	MESH:C116963
28018128	1196	1205	topotecan	Chemical	MESH:D019772
28018128	1246	1255	Belotecan	Chemical	MESH:C116963
28018128	1286	1295	topotecan	Chemical	MESH:D019772
28018128	1311	1315	SCLC	Disease	MESH:D055752
28018128	1316	1324	patients	Species	9606
28018128	1352	1361	belotecan	Chemical	MESH:C116963
28018128	1385	1394	topotecan	Chemical	MESH:D019772
28018128	Positive_Correlation	MESH:C116963	MESH:D012141
28018128	Positive_Correlation	MESH:D019772	MESH:D012141
28018128	Positive_Correlation	MESH:C116963	MESH:D006261
28018128	Negative_Correlation	MESH:D019772	MESH:D055752
28018128	Positive_Correlation	MESH:D019772	MESH:D006261
28018128	Positive_Correlation	MESH:D019772	MESH:D013921
28018128	Comparison	MESH:C116963	MESH:D019772
28018128	Negative_Correlation	MESH:D002166	MESH:D055752
28018128	Negative_Correlation	MESH:C116963	MESH:D055752
28018128	Positive_Correlation	MESH:C116963	MESH:D013921
28018128	Negative_Correlation	MESH:C116963	MESH:D064420

